Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Por um escritor misterioso
Descrição
Frontiers The Clinical and MRI Effect of TNF-α Inhibitors in
Frontiers Use of TNF Inhibitors in Rheumatoid Arthritis and
ASDAS high disease activity versus BASDAI elevation in patients
Immunological Changes in Peripheral Blood of Ankylosing
JCM, Free Full-Text
JCM, Free Full-Text
Tumor Necrosis Factor–α Promoter −308/238 Polymorphism
Disease control in patients with ankylosing spondylitis in real
Frontiers The BASDAI Cut-Off for Disease Activity Corresponding
Disease activity over time in AS patients. ASDAS over time in
Biomarkers for Diagnosis of Axial Spondyloarthritis, Disease
Maintained activity in ankylosing spondylitis patients treated
Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor
Predictors of ASDAS-CRP inactive disease in axial
TNF Inhibitor Therapy, Ankylosing Spondylitis
de
por adulto (o preço varia de acordo com o tamanho do grupo)